Literature DB >> 1697039

Beta 2-microglobulin restriction of antigen presentation.

B Pérarnau1, C A Siegrist, A Gillet, C Vincent, S Kimura, F A Lemonnier.   

Abstract

Antigens are generally thought to be recognized by cytotoxic T lymphocytes as peptides in the context of class I major histocompatibility proteins complex, which are heterodimers of heavy chains noncovalently associated with beta 2-microglobulin (beta 2m). The highly polymorphic nature of the heavy chains and their resulting ability to present different sets of peptides has presumably evolved to allow potent immune responses against most pathogens. By contrast, the polymorphism of beta 2m is limited; seven alleles are known in the mouse and only one has been identified in humans. beta 2-Microglobulin was consequently thought to have only structural functions: namely, to ensure correct folding of class I molecules and their transport to the cell surface. Although beta 2m is not implicated directly in the formation of the peptide binding site, we report here that it participates in the selection of MHC class I molecule-associated peptides.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1697039     DOI: 10.1038/346751a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  21 in total

1.  Transgenic rescue implicates beta2-microglobulin as a diabetes susceptibility gene in nonobese diabetic (NOD) mice.

Authors:  E E Hamilton-Williams; D V Serreze; B Charlton; E A Johnson; M P Marron; A Mullbacher; R M Slattery
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

2.  HLA-B27 heavy chains contribute to spontaneous inflammatory disease in B27/human beta2-microglobulin (beta2m) double transgenic mice with disrupted mouse beta2m.

Authors:  S D Khare; J Hansen; H S Luthra; C S David
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

3.  Sequence divergence of B2m alleles of wild Mus musculus and Mus spretus implies positive selection.

Authors:  E Hermel; P J Robinson; J X She; K F Lindahl
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

Review 4.  Iron overload and immunity.

Authors:  Graça Porto; Maria De Sousa
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

5.  The critical role of CD4+ T cells in PD-1 blockade against MHC-II-expressing tumors such as classic Hodgkin lymphoma.

Authors:  Joji Nagasaki; Yosuke Togashi; Takeaki Sugawara; Makiko Itami; Nobuhiko Yamauchi; Junichiro Yuda; Masato Sugano; Yuuki Ohara; Yosuke Minami; Hirohisa Nakamae; Masayuki Hino; Masahiro Takeuchi; Hiroyoshi Nishikawa
Journal:  Blood Adv       Date:  2020-09-08

6.  HLA-G expression during preimplantation human embryo development.

Authors:  A Jurisicova; R F Casper; N J MacLusky; G B Mills; C L Librach
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

7.  Unexpected beta2-microglobulin sequence diversity in individual rainbow trout.

Authors:  B P Shum; K Azumi; S Zhang; S R Kehrer; R L Raison; H W Detrich; P Parham
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

8.  Allelic variation in class I K gene as candidate for a second component of MHC-linked susceptibility to type 1 diabetes in non-obese diabetic mice.

Authors:  K Inoue; H Ikegami; T Fujisawa; S Noso; K Nojima; N Babaya; M Itoi-Babaya; S Makimo; T Ogihara
Journal:  Diabetologia       Date:  2004-04       Impact factor: 10.122

Review 9.  The Double-Edged Sword of Beta2-Microglobulin in Antibacterial Properties and Amyloid Fibril-Mediated Cytotoxicity.

Authors:  Shean-Jaw Chiou; Huey-Jiun Ko; Chi-Ching Hwang; Yi-Ren Hong
Journal:  Int J Mol Sci       Date:  2021-06-13       Impact factor: 5.923

10.  Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease.

Authors:  Richard J Perrin; Rebecca Craig-Schapiro; James P Malone; Aarti R Shah; Petra Gilmore; Alan E Davis; Catherine M Roe; Elaine R Peskind; Ge Li; Douglas R Galasko; Christopher M Clark; Joseph F Quinn; Jeffrey A Kaye; John C Morris; David M Holtzman; R Reid Townsend; Anne M Fagan
Journal:  PLoS One       Date:  2011-01-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.